NCT00002456: Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation |
|
|
| Completed | 3 | | US | cyclosporine, methotrexate, allogeneic bone marrow transplantation | Fred Hutchinson Cancer Center | Graft Versus Host Disease, Leukemia, Lymphoma | | 04/02 | | |
NCT00003414: Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease |
|
|
| Completed | 3 | 50 | US | aldesleukin, recombinant interferon gamma, busulfan, cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation, radiation therapy | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI) | Graft Versus Host Disease, Lymphoma | 05/04 | 05/04 | | |
NCT00003187: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma |
|
|
| Completed | 2/3 | 19 | US | filgrastim, cyclophosphamide, cyclosporine, cytarabine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy | Virginia Commonwealth University, National Cancer Institute (NCI) | Leukemia, Lymphoma, Myelodysplastic Syndromes | 02/05 | 02/05 | | |